Treatment with bevacizumab and FOLFOXIRI in patients with advanced colorectal cancer: presentation of two novel trials (CHARTA and PERIMAX) and review of the literature

Treatment with bevacizumab and FOLFOXIRI in patients with advanced colorectal cancer: presentation of two novel trials (CHARTA and PERIMAX) and review of the literature

<p>Abstract</p> <p>Background</p> <p>More than half of patients with colorectal cancer will develop metastatic disease either evident at the time of initial diagnosis or during their course of disease. Besides multidisciplinary management further treatment intensificati...

Full description

Bibliographic Details
Main Authors: Stein Alexander, Glockzin Gabriel, Wienke Andreas, Arnold Dirk, Edelmann Thomas, Hildebrandt Bert, Hollerbach Stephan, Illerhaus Gerald, Königsrainer Alfred, Richter Michael, Schlitt Hans J, Schmoll Hans-Joachim
Format: Article
Language:English
Published: BMC 2012-08-01
Series:BMC Cancer
Subjects:
FOLFOXIRI
Bevacizumab
Metastatic colorectal cancer
Resectable liver metastases
Online Access:http://www.biomedcentral.com/1471-2407/12/356

Internet

http://www.biomedcentral.com/1471-2407/12/356

Similar Items